ICON Experts Outline Successful Development Strategies At Drug Information Association 50th Annual Meeting

Published: Jun 12, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Dublin, Ireland, 12 June, 2014 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its participation at the Drug Information Association (DIA) 50th Annual Meeting, taking place from June 15th in San Diego, USA.

ICON experts, including ICON’s Chief Medical Officer, Professor Brendan Buckley, will educate attendees on a range of topics, including innovative partnering models and outsourcing strategies, risk-based monitoring, functional service provision, novel adaptive design approaches and clinical outcomes assessment. Attendees will also be able to meet ICON senior executives and learn more about ICON’s range of services by visiting the ICON booth (#1305) and the Aptiv Solutions booth (#1711) in the exhibit hall.

The full programme of ICON speakers is as follows:

Tuesday, June 17th
08:00 - 09:30 Big data, big impact: new levels of strategic partnerships between sponsors and CROs Professor Brendan Buckley, Chief Medical Officer
08:00 - 09:30 Interpreting treatment effects from Patient Reported Outcome (PRO) endpoints: patient global ratings of concept versus change.

Cicely Kerr Lead Outcomes Researcher, Commercialisation & Outcomes

View an introduction to Cicely’s presentation here.

10:30 - 12:00 Risk-based monitoring: from concept to practice.

Dr. Nick Alp, Vice President, Drug Development Services

View an introduction to Nick's presentation here.

13:00 - 15:00 Computer System Validation in the 21st century: a customer’s perspective. Mark Connolly, Head of IT Applications
Wednesday June 18th
10:30 - 12:00 Occupying the white space between the clinical data manager (CDM) and the clinical research associate (CRA).

Dermot Kenny, Exec VP Global Clinical & Data Operations

View an introduction to Dermot's presentation here.

10:30 - 12:00 Innovative dose-finding using novel adaptive design and analysis approaches. Dr. Silke Jörgens, Senior Statistical Consultant, Aptiv Solutions, an ICON plc company
13:30 - 15:00 FSP driven by KPIs, delivering quality and reduced timelines.

Rose Kidd, VP Clinical Operations

View an introduction to Rose's presentation here.

Thursday June 19th
10:45 - 12:15 Experience conducting studies with risk-based monitoring strategies. Nycole Olivo, CRA, Senior Manager

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 11,100 employees operating in 38 countries.

Further information is available at www.iconplc.com

About DIA
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices and related medical products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and wellbeing worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China.

Further information is available at www.diahome.org

ICON Media Contact
Rebecca Power
Weber Shandwick
Tel: +44 (0) 207 067 0866

Help employers find you! Check out all the jobs and post your resume.

Back to news